Author: CMBlu Energy, Inc.

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

May 18, 2026
CMBlu Surpasses €1B+ Unicorn Threshold with €50M Initial Close of Series C, Defining Baseload Infrastructure for AI and Data Centers

April 30, 2026

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact